Eli Lilly recently announced that, starting from January 1, 2027, three of its drugs—Zepbound, Mounjaro, and Orforglipron—will be officially included in the coverage of Medicare Part D plans.

After the Supreme Court's latest ruling on tariffs, Hewlett Packard Enterprise's CFO stated that the company is continuing to closely monitor subsequent policy developments.

Despite facing pressure from rising product prices, HPE's Chief Financial Officer stated that the company's current market demand remains strong.

Hewlett Packard Enterprise CFO recently revealed that the company's strategic focus for the remainder of this year will shift towards prioritizing orders for products with higher profit margins.

Hewlett Packard Enterprise's Chief Financial Officer stated that the company's performance guidance is the most accurate estimate based on currently available information.